male incontinence advanced treatments, stem cell therapy male incontinence, ProACT periurethral balloons, male incontinence clinical decision making, Analysis of Treatment Options for Male Stress ...

cost-effectiveness bladder cancer, trimodal therapy vs cystectomy, TMT cost-effectiveness, muscle-invasive bladder cancer economics, Cost-Effectiveness Comparison of Bladder Preservation vs Radical ...

PSMA and Beyond 2025 PSMAfore trial, SPLASH trial, ECLIPSE trial, PSMA radioligand therapy, PSMAfore compared to SPLASH, SPLASH LuPSMA arm, PSMAfore LuPSMA arm, ProstACT GLOBAL.

(UroToday.com) The 2025 European Association of Urology (EAU) Annual Congress held in Madrid, Spain, between March 21 st and 24 th 2025, was host to a thematic session on hot topics in the management ...

CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC CG Oncology, Inc.

The 34rd World Congress of Endourology (WCE) held in Conjunction with the South African Urological Association (SAUA) Meeting in 2016 was held in Cape Town, South Africa from November 8th-12th, 2016.

James Wysock joins Zachary Klaassen to discuss improving prostate cancer diagnostics through better biopsy needle technology. Dr. Wysock highlights early experience with the SUREcore® Biopsy Needle ...

Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. August 7, 2025 ...

PSMA and Beyond 2025 antibody drug development (ADC) in prostate cancer, ADC program in advance prostate cancer, PSMA expression, ...

Erectile Dysfunction - Read the latest Erectile Dysfunction research including Full-Text Abstracts as well as "Beyond the Abstract" articles, written by the researchers exclusively for UroToday.

Prostatitis - Read the latest Prostatitis research including Full-Text Abstracts as well as "Beyond the Abstract" articles, written by the researchers exclusively for UroToday.

UroToday's exclusive Video Lecture content covering mCRPC Treatment.